- $31.91bn
- $41.48bn
- $117.76bn
- 64
- 64
- 79
- 79
Annual cashflow statement for Humana, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3,367 | 2,934 | 2,802 | 2,484 | 1,214 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 107 | -1,014 | 231 | 499 | 738 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1,354 | -386 | 809 | 248 | 238 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Gains / Losses on Investment Securities | |||||
Change in Reinsurance Receivable | |||||
Cash from Operating Activities | 5,639 | 2,262 | 4,587 | 3,981 | 2,966 |
Capital Expenditures | -964 | -1,316 | -1,120 | -1,004 | -575 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2,101 | -5,240 | 114 | -2,488 | -2,377 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,065 | -6,556 | -1,006 | -3,492 | -2,952 |
Financing Cash Flow Items | -939 | -337 | 1,987 | 821 | -1,399 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,955 | 3,015 | -1,914 | -856 | -2,487 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 619 | -1,279 | 1,667 | -367 | -2,473 |